Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, April 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Proteomics Software Now Cloud Based!
Monday, January 20, 2014
Scientists compare and interpret proteomics data sets in minutes.

Core Informatics Announces Version 4.2 of their Data Management Software
Thursday, January 16, 2014
New release extends the ability of users to configure personalized applications.

Bruker CAM Launches Bruker Dash Reporting
Thursday, January 16, 2014
NEW SYSTEM seamlessly integrates with Bruker’s MS Workstation data system to generate reports both manually and automatically.

Qlucore Unveils Qlucore Omics Explorer 3.0
Wednesday, January 15, 2014
Omics Explorer 3.0 features new integrated tools which combine measured data with system biology to enable easier, faster and more creative analysis.

LABVANTAGE Releases LABVANTAGE 6.0.2
Wednesday, January 15, 2014
Latest version of this enterprise LIMS offers new capabilities including stability analytics, request management and increased security.

Optibrium Announces a New Release of StarDrop Introducing MPO Explorer
Tuesday, January 14, 2014
The new module, alongside data visualisation enhancements, further extends StarDrop’s capabilities to reduce the time and cost to deliver high quality drug candidates.

Time Dependant Spectroscopy of Microscopic Samples
Thursday, January 09, 2014
CRAIC TimePro™ software is used with CRAIC Technologies microspectrometers to measure the kinetic UV-visible-NIR and fluorescence spectra of microscopic sample areas.

Wyatt Technology to Highlight Expertise in Characterizing Protein Formulations
Wednesday, January 08, 2014
Company will be presenting a short course, two posters and a seminar at PEPTALK 2014.

FDA, EMA Extend Licenses for Aptiv Solutions ADDPLAN® Software
Wednesday, January 08, 2014
FDA purchases novel ADDPLAN® DF Software for improved evaluation of Phase II dose-finding trials.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 780
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv